Company: CI
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001739940-25-000028
Chunk: 155

Company: Cigna Group
Filing Date: 2025-07-31
Form: 10-Q
Item: Part II, Item 7
Chunk 155
---
 Highlights

Consolidated Results of Operations (GAAP basis)Three Months Ended June 30,Six Months Ended June 30,(Dollars in millions)20252024Change20252024ChangePharmacy revenues$53,649 $45,101 19 %$102,282 $87,137 17 %Premiums9,156 11,454 (20)21,892 23,057 (5)Fees and other revenues4,137 3,647 13 8,032 6,973 15 Net investment income236 321 (26)474 611 (22)Total revenues67,178 60,523 11 132,680 117,778 13 Pharmacy and other service costs53,268 44,492 20 101,666 85,923 18 Medical costs and other benefit expenses7,749 9,515 (19)18,247 18,955 (4)Selling, general and administrative expenses3,433 3,684 (7)7,646 7,389 3 Amortization of acquired intangible assets422 420 — 844 843 — Total benefits and expenses64,872 58,111 12 128,403 113,110 14 Income from operations2,306 2,412 (4)4,277 4,668 (8)Interest expense and other(337)(375)(10)(699)(697)— Gain (loss) on sale of businesses— — N/M41 (19)N/MNet investment gains (losses)52 (48)N/M50 (1,884)N/MIncome before income taxes2,021 1,989 2 3,669 2,068 77 Total income taxes389 360 8 628 651 (4)Net income1,632 1,629 — 3,041 1,417 115 Less: Net income attributable to noncontrolling interests100 81 23 186 146 27 Shareholders' net income$1,532 $1,548 (1)%$2,855 $1,271 125 %Consolidated effective tax rate19.2 %18.1 %110 bps17.1 %31.5